Abstract

Influenza viruses are a major public health problem. Vaccines are the best available countermeasure to induce effective immunity against infection with seasonal influenza viruses; however, the breadth of antibody responses in infection versus vaccination is quite different. Here, we show that nasal infection controls two sequential processes to induce neutralizing IgG antibodies recognizing the hemagglutinin (HA) of heterotypic strains. The first is viral replication in the lung, which facilitates exposure of shared epitopes that are otherwise hidden from the immune system. The second process is the germinal center (GC) response, in particular, IL-4 derived from follicular helper T cells has an essential role in the expansion of rare GC-B cells recognizing the shared epitopes. Therefore, the combination of exposure of the shared epitopes and efficient proliferation of GC-B cells is critical for generating broadly-protective antibodies. These observations provide insight into mechanisms promoting broad protection from virus infection.

The reasons why influenza infection promotes a broader antibody response compared with vaccines are not fully understood. Here the authors show that unmasking of haemagglutinin epitopes and IL-4 signals in the germinal centre contribute to broader antibody responses after infection.

Details

Title
Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells
Author
Miyauchi Kosuke 1 ; Adachi, Yu 2 ; Tonouchi Keisuke 2 ; Yajima Taiki 3 ; Harada Yasuyo 3 ; Fukuyama Hidehiro 4 ; Deno Senka 5 ; Iwakura Yoichiro 6   VIAFID ORCID Logo  ; Yoshimura Akihiko 7 ; Hasegawa Hideki 8 ; Yugi Katsuyuki 9 ; Fujii Shin-ichiro 10 ; Ohara Osamu 11 ; Takahashi, Yoshimasa 2   VIAFID ORCID Logo  ; Kubo Masato 12   VIAFID ORCID Logo 

 Laboratory for Cytokine Regulation, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255) 
 National Institute of Infectious Diseases, Research Center for Drug and Vaccine Development, Tokyo, Japan (GRID:grid.410795.e) (ISNI:0000 0001 2220 1880) 
 Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Chiba, Japan (GRID:grid.143643.7) (ISNI:0000 0001 0660 6861) 
 Laboratory for Lymphocyte Differentiation, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255) 
 Laboratory for Integrated Cellular Systems, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255); Institute for Advanced Biosciences, Keio University, Kanagawa, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); Systems Biology Program, Graduate School of Media and Governance, Keio University, Kanagawa, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959) 
 Center for Animal Disease Models, Research Institute for Biomedical Science, Tokyo University of Science, Chiba, Japan (GRID:grid.143643.7) (ISNI:0000 0001 0660 6861) 
 Keio University School of Medicine, Department of Microbiology and Immunology, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959) 
 Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan (GRID:grid.410795.e) (ISNI:0000 0001 2220 1880) 
 Laboratory for Integrated Cellular Systems, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255); Institute for Advanced Biosciences, Keio University, Kanagawa, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959) 
10  Laboratory for Immunotherapy, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255) 
11  Laboratory for Integrative Genomics, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255) 
12  Laboratory for Cytokine Regulation, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255); Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Chiba, Japan (GRID:grid.143643.7) (ISNI:0000 0001 0660 6861) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2542532420
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.